Dow Down 0.18% Nasdaq Up 0.39%

Zogenix, Inc. (ZGNX)

-NasdaqGM
1.35 0.00(0.00%) 4:00PM EDT
|After Hours : 1.36 Up 0.01 (0.74%) 7:40PM EDT
Prev Close:1.35
Open:1.38
Bid:1.02 x 100
Ask:1.38 x 22500
1y Target Est:3.10
Beta:2.28
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:1.31 - 1.43
52wk Range:1.18 - 5.19
Volume:2,435,416
Avg Vol (3m):3,529,910
Market Cap:190.41M
P/E (ttm):N/A
EPS (ttm):-0.75
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ZGNX

Comparison

Symbol% ChgMkt Cap
ZGNX 0.00%190.41M
AZNDown 1.80%94.27B
GSKDown 1.65%115.99B
PFEDown 0.44%185.53B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.68
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:1.2
PEG Ratio (5 yr expected):-0.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company’s commercial product includes Zohydro, a single-entity extended-release hydrocodone for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback